The 20 Best Mantle Cell Lymphoma (MCL) Doctors Near Me in San Francisco, CA

Dr. Wei Ai is a blood cancer specialist who cares for adults with conditions such as Hodgkin's lymphoma and non-Hodgkin's lymphoma, including cutaneous lymphomas, which primarily involve the skin. She also sees patients needing blood and bone marrow transplantation. In her research, Ai focuses on novel approaches to lymphoma treatment, especially targeted agents for T-cell lymphomas. Her studies often lead to clinical trials of new therapies that target cancer at the molecular level. Ai earned a doctoral degree in microbiology and immunology as well as her medical degree from Stanford University School of Medicine. She completed a residency in internal medicine at UCSF, followed by fellowship training in medical oncology at Stanford. Dr. Ai is rated as a Distinguished provider by MediFind in the treatment of Mantle Cell Lymphoma (MCL). Her top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), T-Cell Lymphoma, Hodgkin Lymphoma, and Bone Marrow Aspiration.

Dr. Spencer Behr is a radiologist with expertise in molecular imaging, radiation therapy and abdominal imaging. He has a special interest in radiomics, extracting data from medical images that can be used to better predict and assess a patient's response to cancer treatment. Behr pursues translational research – applying laboratory findings to the development of medical therapies – on the use of molecular and hybrid imaging to better treat prostate cancer. He is particularly interested in new radiology techniques that combine PET scanning with CT or MRI. He has pursued research projects that involve collaboration among multiple departments, aiming to foster discussions among specialists of various disciplines and to optimize the impact of these studies on patient care. Behr earned his medical degree from Tufts University School of Medicine. He completed a residency in diagnostic radiology at Lahey Hospital & Medical Center, serving as chief resident. At UCSF, he completed fellowships in abdominal imaging and nuclear medicine. Behr enjoys mentoring medical students, residents and fellows, and has received national recognition for his excellence in teaching and mentoring. He serves as fellowship director for radiology and biomedical imaging, co-director of the Helen Diller Family Comprehensive Cancer Center's Cancer Imaging Research Shared Resource and vice chair of UCSF's Committee on Rules & Jurisdiction. Dr. Behr is rated as an Advanced provider by MediFind in the treatment of Mantle Cell Lymphoma (MCL). His top areas of expertise are Neuroendocrine Tumor, Ureterocele, WT1-Related Wilms Tumor Syndromes, Pancreaticoduodenectomy, and Prostatectomy.

Dr. Derek Sun is a radiologist who interprets medical imaging that includes X-rays, ultrasound images, CT scans and MRI. He has a particular interest in diseases and conditions of the abdomen and pelvis. Sun earned his medical degree at Albert Einstein College of Medicine. He completed a residency in radiology at NYC Health + Hospitals/Jacobi, followed by a fellowship in abdominal imaging at UCSF. Sun is passionate about educating physicians-in-training. He serves as associate director of UCSF’s program in abdominal imaging and ultrasound, for which he teaches high-level concepts in medical imaging. He received the Hideyo Minagi Outstanding Teacher Award in 2019. A native San Franciscan, Sun enjoys giving back to his community. He volunteers at a local food bank and promotes STEM education (science, technology, engineering and mathematics) to Bay Area students. Dr. Sun is rated as an Advanced provider by MediFind in the treatment of Mantle Cell Lymphoma (MCL). His top areas of expertise are Chronic Cough, Fibrolamellar Carcinoma, WT1-Related Wilms Tumor Syndromes, Progressive Familial Intrahepatic Cholestasis Type 2, and Small Bowel Resection.

Dr. Robert Flavell is a radiologist who cares for both adults and children, and specializes in nuclear medicine, the use of small amounts of radioactive materials to evaluate organ systems. He is chief of molecular imaging and therapeutics for the UCSF Department of Radiology and Biomedical Imaging. In research, Flavell focuses on developing new methods of diagnosing and treating cancer using molecular imaging technology, which shows what is taking place in the body at a cellular and molecular level. After earning a doctorate in chemical biology at the Rockefeller University, Flavell earned his medical degree at Weill Cornell Medicine. At UCSF, he completed a residency in diagnostic radiology, followed by a fellowship in nuclear medicine. Dr. Flavell is rated as an Advanced provider by MediFind in the treatment of Mantle Cell Lymphoma (MCL). His top areas of expertise are Neuroendocrine Tumor, Gastrointestinal Stromal Tumor, Smoldering Multiple Myeloma, and Fibrolamellar Carcinoma.

Dr. Charalambos (Babis) Andreadis specializes in bone marrow transplantation for adults and in treating Hodgkin's and non-Hodgkin's lymphoma, leukemia and multiple myeloma. He cares for patients at the UCSF Helen Diller Family Comprehensive Cancer Center. His research, published widely in scientific journals, examines genetic and other factors that affect how patients respond to therapy, including degrees of drug toxicity. He also studies patient outcomes in these disorders. Andreadis earned his medical degree at Columbia University's Vagelos College of Physicians and Surgeons, and was elected to the Alpha Omega Alpha Honor Medical Society in 1998. He completed a residency at New York-Presbyterian Hospital and a fellowship in hematology and oncology at the Hospital of the University of Pennsylvania, where he joined the faculty in 2004. He also earned a master's degree in clinical epidemiology at the University of Pennsylvania, focusing on pharmacogenetics, the study of how genes impact an individual's response to medications. Dr. Andreadis is rated as a Distinguished provider by MediFind in the treatment of Mantle Cell Lymphoma (MCL). His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.

Caring, compassionate, and patient centric care. Dr. Quock is rated as an Experienced provider by MediFind in the treatment of Mantle Cell Lymphoma (MCL). His top areas of expertise are Small Cell Lung Cancer (SCLC), Thrombocytopenia, Pleuropulmonary Blastoma, Lung Cancer, and Bone Marrow Aspiration.

caring, good listener, dedicated, intelligent, compassionate, committed, healing and reassuring. Dr. Chan is rated as an Experienced provider by MediFind in the treatment of Mantle Cell Lymphoma (MCL). His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, Nasopharyngeal Carcinoma, and Bone Marrow Aspiration.

Jonathan Lee is a primary care provider, practicing in Family Medicine in San Francisco, California. Dr. Lee is rated as an Experienced provider by MediFind in the treatment of Mantle Cell Lymphoma (MCL). His top areas of expertise are Maturity Onset Diabetes of the Young, Mantle Cell Lymphoma (MCL), Familial Hypertension, and Hypertension. Dr. Lee is currently accepting new patients.

Rizwan Aslam is a Radiologist in San Francisco, California. Dr. Aslam is rated as an Advanced provider by MediFind in the treatment of Mantle Cell Lymphoma (MCL). His top areas of expertise are Lymphofollicular Hyperplasia, Splenomegaly, Chylous Ascites, and Kimura Disease.

Donald Abrams is an Oncologist in San Francisco, California. Dr. Abrams is rated as an Experienced provider by MediFind in the treatment of Mantle Cell Lymphoma (MCL). His top areas of expertise are Angiosarcoma, Small Cell Lung Cancer (SCLC), Inflammatory Breast Cancer, and Familial Prostate Cancer.

Courtney Lawhn is a Radiologist in San Francisco, California. Dr. Lawhn is rated as an Experienced provider by MediFind in the treatment of Mantle Cell Lymphoma (MCL). Her top areas of expertise are Neuroendocrine Tumor, Smoldering Multiple Myeloma, Gastrointestinal Stromal Tumor, Fibrolamellar Carcinoma, and Prostatectomy.

Dr. Lawrence D. Kaplan, a hematologist-oncologist, directs UCSF's lymphoma program. He is an international leader in the treatment of lymphoma and HIV-associated lymphoma. In his research, Kaplan is particularly interested in developing new treatments for lymphoma and the HIV-related form of this cancer. Kaplan earned his medical degree at the David Geffen School of Medicine at UCLA. He completed a residency in medicine at Boston Medical Center and completed a fellowship in hematology and oncology at UCSF. He joined UCSF in 1985. Kaplan's professional activities include serving on the Lymphoma Working Group of the AIDS Malignancy Consortium, a clinical trials group supported by the National Cancer Institute (NCI). He formerly chaired the group's steering committee. He also serves on the lymphoma committee of Alliance for Clinical Trials in Oncology, a national research group sponsored by the NCI. Dr. Kaplan is rated as an Advanced provider by MediFind in the treatment of Mantle Cell Lymphoma (MCL). His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.

Thomas Hope is a Radiologist in San Francisco, California. Dr. Hope is rated as an Experienced provider by MediFind in the treatment of Mantle Cell Lymphoma (MCL). His top areas of expertise are Neuroendocrine Tumor, Undifferentiated Pleomorphic Sarcoma, Mesenchymoma, Prostatectomy, and Parathyroidectomy.

Michael Spinner is a Hematologist in San Francisco, California. Dr. Spinner is rated as an Advanced provider by MediFind in the treatment of Mantle Cell Lymphoma (MCL). His top areas of expertise are Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Wei Wang is an Oncologist in San Francisco, California. Dr. Wang is rated as an Advanced provider by MediFind in the treatment of Mantle Cell Lymphoma (MCL). His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Inflammatory Breast Cancer, and Angiosarcoma.

Dr. Rena Fox is an internal medicine specialist and an expert in hepatitis C, making her one of the few doctors in the country with this distinct combination of qualifications. She cares for patients with general health needs as well as those with viral hepatitis and liver disease. She teaches internal medicine residents as part of her primary care practice. As a researcher, Fox studies liver diseases such as hepatitis C and fatty liver disease, and factors such as which populations tend to be affected. Contributing to large studies conducted across multiple centers, she also researches long-term outcomes for patients with liver disease, such as hepatocellular carcinoma (the most common type of liver cancer) and cirrhosis. Fox earned her medical degree at the University of California, San Diego and completed a residency in internal medicine at the University of Washington. She completed a UCSF fellowship in general internal medicine with a particular interest in hepatitis C, receiving training from UCSF hepatologists in viral hepatitis. Fox is internationally recognized as an educator. She lectures around the country and has been working with the Department of Veterans Affairs for more than a decade, developing educational tools and national policies on hepatitis C. She also serves as medical editor of the VA's viral hepatitis and liver disease website. Fox serves on the faculty of UCSF's Hepatitis C Project ECHO (Extension for Community Healthcare Outcomes), which remotely supports providers in underserved and rural areas by offering information and guidance on hepatitis C screening and care via telemedicine. Dr. Fox is rated as an Experienced provider by MediFind in the treatment of Mantle Cell Lymphoma (MCL). Her top areas of expertise are Hepatitis C, Hepatitis, Liver Cancer, and Non-Alcoholic Fatty Liver Disease.

A leading expert in hematology-oncology, Dr. Thomas Martin is associate director of UCSF's myeloma program and director of the unrelated donor transplantation programs for adults at UCSF Medical Center. Martin is clinical research director of hematologic malignancies (blood cancers) at the UCSF Helen Diller Family Comprehensive Cancer Center. His research interests include developing treatments for myeloma and leukemia as well as expanding the use of bone marrow transplants. He has a special interest in umbilical cord blood transplants, and he is involved in efforts to improve outcomes for patients who have transplants from unrelated donors. Martin earned an undergraduate degree at Cornell University and his medical degree at the University of Connecticut School of Medicine. After a medical residency at Harbor-UCLA Medical Center, he completed a fellowship in hematology-oncology at UCSF. In 1999, he joined MD Anderson Cancer Center as an assistant professor of medicine. In 2001, he returned to UCSF. Dr. Martin is rated as an Experienced provider by MediFind in the treatment of Mantle Cell Lymphoma (MCL). His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Dr. Peter Sayre specializes in adult bone marrow transplantation and other treatments for leukemia, multiple myeloma, lymphoma and Hodgkin's disease. Sayre is a director of clinical research at UCSF. His research interests focus on allogeneic stem cell transplants (which use cells from a matching donor) and leukemia in older adults. His work on these subjects has been widely published in medical and other scientific journals. Sayre earned an undergraduate degree in philosophy from Yale College, graduating magna cum laude. He earned his medical degree at the Rutgers Robert Wood Johnson Medical School, and he earned a doctorate in immunology at Harvard University. He completed a fellowship in hematology and oncology at UCSF before joining the faculty in 1996. Dr. Sayre is rated as an Experienced provider by MediFind in the treatment of Mantle Cell Lymphoma (MCL). His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Multiple Myeloma, Bone Marrow Aspiration, and Bone Marrow Transplant.

Dr. Rebecca Olin is a hematologist who specializes in bone marrow transplantation in adults. Her expertise encompasses treating acute leukemia, myelodysplastic and myeloproliferative disorders (conditions in which the bone marrow makes too many white blood cells) and aplastic anemia (a condition in which the body doesn’t make enough new blood cells). In her research, Olin has a particular interest in studying how best to treat blood cancers in older patients, some of whom may require a bone marrow transplant. Olin earned her medical degree from the Perelman School of Medicine at the University of Pennsylvania and was elected to the Alpha Omega Alpha Honor Medical Society. She completed a residency in internal medicine as well as a fellowship in hematology and oncology at the Hospital of the University of Pennsylvania, serving as chief fellow for one year. She also has a master's degree in clinical epidemiology, with a focus on medical decision making, from the University of Pennsylvania. Dr. Olin is rated as an Experienced provider by MediFind in the treatment of Mantle Cell Lymphoma (MCL). Her top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Lymphoblastic Leukemia (ALL), Bone Marrow Transplant, and Bone Marrow Aspiration.

Dr. Jeffrey L. Wolf is a hematologist with expertise in cancers of the bone marrow and blood, as well as in bone marrow transplantation to treat these cancers. His primary focus in both patient care and research is myeloma, the second most common blood cancer. He directs UCSF's Multiple Myeloma Program and the Stephen and Nancy Grand Multiple Myeloma Translational Initiative – a program to support the development of better treatments – at the UCSF Helen Diller Family Comprehensive Cancer Center. Wolf's current research interests are in measuring minimal residual disease in patients who have undergone successful treatment for myeloma, as the results are useful in predicting long-term survival. Wolf earned his medical degree at the University of Illinois College of Medicine at Chicago and completed a residency in medicine at the University of California, San Diego. He completed a fellowship in hematology and oncology at UCSF, followed by a bone marrow transplantation rotation at the Fred Hutchinson Cancer Research Center. In 1979, Wolf helped establish the bone marrow transplant program at the City of Hope Comprehensive Cancer Center in Duarte, California. In 1984, he helped establish the first bone marrow transplant unit based at a community hospital in the United States, at Alta Bates Summit Medical Center in Berkeley. He joined UCSF in 2007. Dr. Wolf is rated as an Experienced provider by MediFind in the treatment of Mantle Cell Lymphoma (MCL). His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.